טוען...
ERα-targeted endocrine therapy, resistance and the role of GPER
Endocrine therapy is an effective option for the treatment of estrogen receptor alpha (ERα)-positive breast cancers. Unfortunately, a large fraction of women relapse with endocrine-resistant tumors. The presence of constitutively active ERα mutants, found in a subset of relapse tumors, is thought to...
שמור ב:
| הוצא לאור ב: | Steroids |
|---|---|
| Main Authors: | , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2019
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6859199/ https://ncbi.nlm.nih.gov/pubmed/31518595 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.steroids.2019.108493 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|